4DX

0.95%

52.0¢ 4dmedical limited

Ann: Application for quotation of securities - 4DX, page-82

First 82 Last

Share
Profile

Follow
slick351

500 Posts.

3

26/07/24

16:08

Post #: 74935596
Share

Originally posted by Frederic0: ↑

Trust that AI ...

-----

In the case of a medical company engaged in extensive research and development (R&D), dilution can indeed be beneficial in the long run, especially if the company is working towards strategic goals with the potential for significant future revenue.

Here are some key points to consider:
1. **Funding R&D**: Medical research is capital-intensive and often requires substantial investment over extended periods. Issuing new shares to fund R&D can ensure the company has the necessary resources to continue its projects without relying heavily on debt, which could be risky.

2. **Pipeline Development**: If the company's research is progressing well and is close to achieving breakthroughs, the additional funding from share issuance can expedite the development process. This can include advancing clinical trials, obtaining regulatory approvals, and scaling up production.

3. **Long-term Value Creation**: Successful R&D in the medical field can lead to the development of new treatments, drugs, or medical devices that can generate significant revenue. If the company achieves its strategic goals, the long-term value created can far outweigh the short-term dilution of shares.

4. **Market Positioning**: A medical company with a strong pipeline of innovative products can enhance its market position, attract strategic partners, and increase its competitive advantage. This can lead to higher market share and sustained revenue growth.

5. **Investor Confidence**: Transparent communication about the progress of research and the strategic use of funds can maintain and even boost investor confidence. Investors may be more willing to accept short-term dilution if they believe in the long-term potential and strategic direction of the company.

6. **Risk Mitigation**: Dilution spreads the financial risk among a larger base of shareholders, reducing the burden on existing investors. This can be particularly important in the high-risk, high-reward environment of medical research.

While the delay in realizing revenue might cause some short-term concerns, the critical factor is the company's potential to achieve its strategic goals and deliver significant long-term returns. If the company demonstrates progress and clear potential for future success, the dilution can be justified as a necessary step towards achieving those objectives.

Expand

Another week no announcements, when is the quarterly due?
Do we think we will get any announcements anytime soon, before we drop into the 40c again

4DX Price at posting: 51.8¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

EQN

Equinox unveils some of "world's highest" antimony grades at Alturas, Canada

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

ASX Market Open: Green Friday as markets digest Trump; China | 8 Nov 2024

NMR

NMR picks up advanced gold projects in far north Queensland

AKN

AuKing Mining flags gold in rock chips on-site Saudi Shaib Marqan project

Trump is President Again: What Does This Mean for Crypto?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

There are more pages in this discussion • 10 more messages in this thread...

First 82 Last

Add 4DX (ASX) to my watchlist

(20min delay)
Last 52.0¢		Change -0.005(0.95%)		Mkt cap ! $213.4M

Open	High	Low	Value	Volume
52.0¢	53.5¢	51.0¢	$175.2K	337.1K

Buyers (Bids)

No.	Vol.	Price($)
6	173020	51.0¢

Sellers (Offers)

Price($)	Vol.	No.
52.0¢	162258	3

View Market Depth

No.	Vol.	Price($)
6	173020	0.510
2	20417	0.505
12	137800	0.500
1	750	0.495
2	55081	0.490

Price($)	Vol.	No.
0.520	162258	3
0.535	15160	2
0.540	43833	4
0.545	10000	1
0.550	15010	3

Last trade - 16.10pm 08/11/2024 (20 minute delay)

4DX (ASX) Chart

Ann: Application for quotation of securities - 4DX, page-82

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Universal Biosensors flat despite fresh deal with US medical product distributor

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Equinox unveils some of "world's highest" antimony grades at Alturas, Canada

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

ASX Market Open: Green Friday as markets digest Trump; China | 8 Nov 2024

NMR picks up advanced gold projects in far north Queensland

AuKing Mining flags gold in rock chips on-site Saudi Shaib Marqan project

Trump is President Again: What Does This Mean for Crypto?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Application for quotation of securities - 4DX, page-82

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Universal Biosensors flat despite fresh deal with US medical product distributor

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

Equinox unveils some of "world's highest" antimony grades at Alturas, Canada

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

ASX Market Open: Green Friday as markets digest Trump; China | 8 Nov 2024

NMR picks up advanced gold projects in far north Queensland

AuKing Mining flags gold in rock chips on-site Saudi Shaib Marqan project

Trump is President Again: What Does This Mean for Crypto?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News